Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations: a systematic review and meta-analysis

Mamaril-Davis, James; Aguilar‐Salinas, Pedro; Ávila, Mauricio J.; Nakaji, Peter; Bina, Robert

doi:10.1007/s10143-021-01724-w

Cited by 4 publications

(2 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Headaches, seizures, and focal neurological deficits can be caused by edema, venous thrombosis, arterial stenoses, and cortical irritation (35,36). If the bAVM is treatable in this situation, curing the bAVM will be the goal, and the outcomes could be excellent, as in the case of epileptic symptoms, for instance (37). Flow related aneurysm need also to be checked because their disappearance after bAVM treatment is not the rule : only if the aneurysm was near to the bAVM nidus did Budohoski et al report a reduction in size (38).…”

Section: Accepted Manuscriptmentioning

confidence: 99%

“…9 47 bAVM treatment can lead to substantial improvement in these symptoms, particularly seizures. 48 When a bAVM is causing symptoms, but cannot be treated solely by the endovascular route, EVT can be used as an adjunct to surgery or radiosurgery (“pre-EVT”), or as a palliative treatment option.…”

Section: General Strategies For the Selection Of Evt For Bavm Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Endovascular Management of Brain Arteriovenous Malformations

et al. 2023

View full text Add to dashboard Cite

Due to the risk of cerebral hemorrhage, and its related morbidity-mortality, brain arteriovenous malformations (bAVM) are a rare and threatening disease. Concerning bAVM management, only one randomized control trial -the ARUBA trial -has been published so far. The results of the ARUBA trial favor a non-interventional approach in the case of an unruptured bAVM, however implementation of these findings is challenging in daily practice.Instead, management relies on multidisciplinary discussions that lead to patient-specific strategies based on local expertise and experience in reference centers. Given the wide patterns of presentation and multiple treatment modalities recommendations are also difficult to follow. Endovascular treatment (EVT) is a widely used modality which can be used for curative treatment, or prior to surgery or radiosurgery ("pre-EVT"). EVT practice is in constant evolution (i.e. venous approach, combination with surgery during the same anesthesia, etc.). Liquid embolic agents (LEA) such as ethylene vinyl alcohol (EVOH) copolymer and cyanoacrylates (CYA), and their method of injection to increase bAVM occlusion, have also benefited from technical evolutions such as the use of adjunctive flow arrest techniques (mini balloons, pressure cooker technique and multiple catheters). Further research is necessary to evaluate the advantages and disadvantages of EVT.

show abstract